MENU
NGNE
AS OF
Dec 24 closing price
Price
$20.07
Change
-$0.01 (-0.05%)
Capitalization
310.88M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Neurogene (NGNE) Ownership - Who owns Neurogene?

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning)... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
310.88M
P/E Ratio
N/A
Total Cash
265.41M
Projected Growth
N/A
Total Debt
11.27M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
17.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

NGNE
Capitalization
311M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
265M
Total Cash/Share
17.13
Total Debt
11.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
266M
P/B Ratio
1.17
Cash Flow
N/A
Earnings
-4.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
18.39
Current Revenue Per Employee
10164.83
Dividends Per Share - Security
N/A
EBITDA
-82.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-37.67
Shares Held By Institutions
317M
Shares Outstanding - Current
15.5M
Total Liabilities
22.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-12.205
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
NGNE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for NGNE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com